Sunday, September 19th | 13 Tishri 5782

March 30, 2020 8:13 am

Intel Israel Donates Money for Coronavirus Testing Machine to Rambam Hospital

avatar by

Cars drive past US chipmaker Intel Corp’s “smart building” in Petah Tikva, near Tel Aviv, Israel December 15, 2019. Photo: REUTERS/Amir Cohen. – Intel Israel announced a donation of NIS 1.25 million (about $339,114) last week to the Rambam Health Care Campus in Haifa to be used for the purchase of a coronavirus testing machine, reported the website NoCamels.

The Genomic STARlet by Hamilton Robotics produces and extracts genetic material from respiratory samples taken from people believed to have COVID-19, said Rambam’s general-director Michael Halbertal.

The automated machine will increase the number of coronavirus tests that can be processed, which then boost the capability of detection and treatment. The hospital will also receive two systems that can detect the presence of the virus, according to NoCamels.

“With these three devices, we will be able to greatly increase the number of tests performed in the laboratory, while maintaining uncompromising quality,” said Halbertal. “The Rambam Hospital and Intel have a long history of collaborations that directly influenced the hospital’s capabilities and our ability to help patients. This time of current crisis is no different.”

Related coverage

September 19, 2021 11:29 am

Israel Ranked 4th in 2021’s Digital Quality of Life Index

CTech - The third annual edition of Surfshark’s Digital Quality of Life Index has revealed that Israel has jumped four...

Intel Israel said in a statement: “We are in challenging times that demand social responsibility and unity … including that of the business sector. Intel Israel’s management and employees see great importance in the social responsibility of helping to deal with the coronavirus crisis affecting us these days.”

The number of Israelis infected with COVID-19 stood at 3,035 as of Friday, according to the Ministry of Health.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.